ARCHIVES

Lynch Named Director, Yale Cancer Center

This article is from The Cancer Letter archive.

Vol. 35 No. 08 | February 27, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Toxicology Program Board To Review Nine Substances.

January 14, 2000

President Obama Names Six NCAB Members

December 7, 2012

Chemo, Radiation Improves DFS In Head & Neck Cancer

May 28, 2004

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981